Case Report on Intravenous Ranitidine Induced Anaphylactic Reaction in Cholangiocarcinoma Patient
Khayati Moudgil1, Sivasankaran Ponnusankar2★★ Corresponding author
- 1Department of Pharmacy Practice, JSS College of Pharmacy, Udhagamandalam- 643001, The Nilgiris, Tamil Nadu, INDIA.
- 2JSS Academy of Higher Education and Research, Mysuru, Karnataka, INDIA.
CORRESPONDENCE
Sivasankaran Ponnusankar
JSS Academy of Higher Education and Research, Mysuru, Karnataka, INDIA.
Volume 10, Issue 4 · pp. 308–311 · PUBLISHED · DOI: 10.5530/ijopp.10.4.64
ABSTRACT
Ranitidine hydrochloride being one of the most commonly used drugs and its use is well provident. Furthermore, anaphylactic reactions are rarely observed with the use of ranitidine hydrochloride. Hypersensitivity reactions are usually common in clinical practice but adverse reaction to intravenous ranitidine is very rare. Here we report a case, where the patient developed an anaphylactic reaction with a single dose of intravenous ranitidine in cholangiocarcinoma patient. This report highlights the importance of recognition of the serious adverse events that might follow and the need for cautiousness with the use of ranitidine in the future prospects.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Moudgil, K., & Ponnusankar, S. (). Case Report on Intravenous Ranitidine Induced Anaphylactic Reaction in Cholangiocarcinoma Patient. Indian Journal of Pharmacy Practice, 10(4), 308–311. https://doi.org/10.5530/ijopp.10.4.64